Imino sugar therapy for type 1 Gaucher disease.
Priestman
D A
DA
Platt
F M
FM
Dwek
R A
RA
Butters
T D
TD
D017485:1-Deoxynojirimycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005776:Gaucher Disease / Q000188:drug therapy* / Q000378:metabolism; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000097:blood; D065089:Glycoside Hydrolase Inhibitors; D006028:Glycosphingolipids / Q000378:metabolism; D006801:Humans; D051379:Mice
D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D006028:Glycosphingolipids; D017485:1-Deoxynojirimycin; C059896:miglustat; D005962:Glucosylceramidase